Annexin A2 promotes development of retinal neovascularization through PI3K/ AKT signaling pathway. (3rd April 2022)

• Record Type: Journal Article
• Authors: Li, Chenyue; Zhao, Zichang; Zhao, Shihong
• Is Part Of: Current eye research. Volume 47:Number 4(2022)
• Page Start: 579
• Page End: 589
• Publication Date: 2022-04-03
• Subjects: Annexin A2 -- human retinal vascular endothelial cell -- retinal neovascularization -- AKT -- PI3K; Ophthalmology -- Periodicals; Eye -- Diseases -- Periodicals; Ophthalmology -- Periodicals; 573.88
• DOI: 10.1080/02713683.2021.2018467
• Languages: English
• ISSNs: 0271-3683

Abstract

ABSTRACT: Purpose: Retinal Neovascularization (RNV) is a pathological characteristic of ocular diseases. Annexin A2 (ANXA2) plays important roles in RNV while the mechanism remains unclear. The study aimed to explore relationship between ANXA2 and PI3K/AKT signaling pathway in RNV. Methods: We used human retinal vascular endothelial cells (HRECs) and oxygen-induced retinopathy (OIR) mice model to show ANXA2 can promote the development of RNV through PI3K/AKT signaling pathway. We divided HRECs into six groups by infecting lentivirus containing appropriate plasmid and adding corresponding solution. Assays showing ability of HRECs were performed in vitro. Mice were randomly divided into three groups and treated accordingly. Results: Expression of ANXA2 and activity of PI3K/AKT signaling pathway in HRECs were detected. RNV and expression of ANXA2 in mice retinas were detected. Results showed that ANXA2 expression is positively related with RNV-forming ability of HRECs in vitro and development of RNV in vivo while low activity of PI3K/AKT signaling pathway could attenuate the role of ANXA2. Conclusions: We can make ANXA2 and PI3K/ AKT signaling pathway as a promising target for the regulation of pathological neovascularization of the retina, which also provides a novel idea for effective prevention and treatment of diseases related to RNV in future.